Eslamizar, L., C. Petrovas, D. J. Leggat, K. Furr, M. L. Lifton, G. Levine, S. Ma, et al. “Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center (Accepted).” In Npj Vaccines, Vol. 6, 2021. https://doi.org/10.1038/s41541-020-00277-1.
Rubio, Adonis A., Maria V. Filsinger Interrante, Benjamin N. Bell, Clayton L. Brown, Theodora U. J. Bruun, Celia C. LaBranche, David C. Montefiori, and Peter S. Kim. “A derivative of the D5 monoclonal antibody that targets the gp41 N-heptad repeat of HIV-1 with broad tier-2 neutralizing activity.” J Virol, May 12, 2021. https://doi.org/10.1128/JVI.02350-20.
Song, Linan, Shuo Wang, Tong Fang, Xiaoguang Qiu, Xiaoli Wang, Xinna Zhou, Michael A. Morse, et al. “Changes in peripheral blood regulatory T cells, and IL-6 and IL-10 levels predict response of pediatric medulloblastoma and germ cell tumors with residual or disseminated disease to craniospinal irradiation.” Int J Radiat Oncol Biol Phys, May 8, 2021. https://doi.org/10.1016/j.ijrobp.2021.04.041.
Telli, Melinda L., Hiroshi Nagata, Irene Wapnir, Chaitanya R. Acharya, Kaitlin Zablotsky, Bernard A. Fox, Carlo B. Bifulco, et al. “Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy.” Clin Cancer Res 27, no. 9 (May 1, 2021): 2481–93. https://doi.org/10.1158/1078-0432.CCR-20-3944.
Werner, Lauryn R., Katelin A. Gibson, Merit L. Goodman, Dominika E. Helm, Katherine R. Walter, Sean M. Holloran, Gloria M. Trinca, et al. “Progesterone promotes immunomodulation and tumor development in the murine mammary gland.” J Immunother Cancer 9, no. 5 (May 2021). https://doi.org/10.1136/jitc-2020-001710.